Eisai Selects Medidata’s Clinical Data Studio to Enhance and Modernize Clinical Trial Efficiency and Patient Experience
AI-enhanced solution will help Eisai accelerate data review and reconciliation by 80%
| ABX | ||
| 2,478.501 | ||
| -30.3570 | -0.0121% | |
| BISNIS-27 | ||
| 494.801 | ||
| -11.3050 | -0.0223% | |
| DBX | ||
| 3,323.193 | ||
| -77.9660 | -0.0229% | |
| ECONOMIC30 | ||
| 99.166 | ||
| -1.8180 | -0.0180% | |
| ESGQKEHATI | ||
| 118.321 | ||
| -1.9470 | -0.0162% | |
| ESGSKEHATI | ||
| 118.988 | ||
| -1.9740 | -0.0163% | |
| I-GRADE | ||
| 189.465 | ||
| -3.6820 | -0.0191% | |
| AUDRP | ||
| 11,723.530 | ||
| -6.4800 | -0.0552% | |
| EURRP | ||
| 19,533.060 | ||
| 15.0900 | 0.0773% | |
| JPYRP | ||
| 105.936 | ||
| 0.0277 | 0.0262% | |
| SINRP | ||
| 13,167.120 | ||
| -4.7300 | -0.0359% | |
| USDRP | ||
| 16,900.000 | ||
| 15.0000 | 0.0888% | |
